Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck digital illustration

Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck Save


ICD-10 code: C84.71

Disease category: C84.7: Anaplastic large cell lymphoma, ALK-negative

Anaplastic Large Cell Lymphoma, ALK-negative, in Lymph Nodes of Head, Face, and Neck

Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma that develops primarily in the lymph nodes. ALCL can also affect other parts of the body, including the skin, bones, soft tissues, and organs. ALCL is categorized into two types: ALK-positive and ALK-negative. ALK-negative ALCL is the less common type of the disease, accounting for approximately 40% of all cases.

ALCL can occur in any lymph node group, but it is particularly prevalent in the lymph nodes of the head, face, and neck. Patients with ALK-negative ALCL may experience swelling, pain, and tenderness in the affected lymph nodes, as well as other symptoms, such as fever, night sweats, and weight loss. In some cases, ALCL can cause skin lesions or nodules, which may be mistaken for an infection or other skin condition.

Diagnosis of ALK-negative ALCL typically involves a combination of physical examination, imaging tests, and a biopsy of the affected lymph node or tissue. The biopsy is then examined under a microscope to determine the presence of cancer cells and to classify the type of lymphoma.

There are several risk factors associated with the development of ALK-negative ALCL, including a weakened immune system, exposure to certain chemicals and pollutants, and genetic mutations. However, the exact cause of the disease is not yet fully understood.

  1. Treatments for ALK-negative ALCL depend on several factors, including the stage and severity of the disease, the patient's age and overall health, and the presence of any underlying medical conditions.
  2. Common treatments for ALCL may include chemotherapy, radiation therapy, targeted therapy, or a combination of these approaches.
  3. Patients with ALK-negative ALCL may also benefit from supportive care, such as pain management, nutritional support, and psychological counseling.
  4. It is important for patients with ALCL to receive regular follow-up care to monitor their condition and to address any side effects or complications that may arise from treatment.

In conclusion, ALK-negative ALCL is a rare but aggressive form of non-Hodgkin lymphoma that primarily affects the lymph nodes of the head, face, and neck. Early diagnosis and prompt treatment are essential for improving outcomes for patients with this disease. If you or a loved one are experiencing symptoms of ALCL, it is important to speak with a healthcare provider to determine the best course of action.

Treatment of Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck:

Anaplastic Large Cell Lymphoma (ALCL) is a rare type of cancer that develops in the lymphatic system. It typically begins in the lymph nodes and can spread to other parts of the body. ALK-negative ALCL is a subtype of the disease that does not have a specific genetic abnormality known as an anaplastic lymphoma kinase (ALK) gene rearrangement. When ALCL affects the lymph nodes of the head, face...

To see full information about treatment please Sign up or Log in